Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias D Hofer

Showing results (81-90 of 103) with videos related to

Pageof 11
Sort By:
Neoplasia (New York, N.Y.)|January 16, 2007
Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancerPamela L Paris, Matthias D Hofer, Giancarlo Albo, et al.
The American Journal of Surgical Pathology|May 29, 2007
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasionSven Perner, Juan-Miguel Mosquera, Francesca Demichelis, et al.
Cancer Research|October 7, 2004
JAGGED1 expression is associated with prostate cancer metastasis and recurrenceSandro Santagata, Francesca Demichelis, Alberto Riva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2010
Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responsesEva-Jasmin Freyschmidt, Clinton B Mathias, Natalia Diaz, et al.
Cancer Research|April 16, 2009
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapyMara P Steinkamp, Orla A O'Mahony, Michele Brogley, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer diseaseKilian M Gust, Matthias D Hofer, Sven R Perner, et al.
Urology|December 19, 2009
ERG rearrangement metastasis patterns in locally advanced prostate cancerSven Perner, Maria A Svensson, Ruhella R Hossain, et al.
Cancer Research|February 12, 2004
The role of metastasis-associated protein 1 in prostate cancer progressionMatthias D Hofer, Rainer Kuefer, Sooryanarayana Varambally, et al.
Abdominal Radiology (New York)|September 10, 2018
MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 studyRehan Ali, Ahmed Gabr, Samdeep K Mouli, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Defining aggressive prostate cancer using a 12-gene modelTarek A Bismar, Francesca Demichelis, Alberto Riva, et al.
Pageof 11

Showing results (81-90 of 103) with videos related to

Sort By:
Pageof 11
Neoplasia (New York, N.Y.)|January 16, 2007
Genomic profiling of hormone-naïve lymph node metastases in patients with prostate cancerPamela L Paris, Matthias D Hofer, Giancarlo Albo, et al.
The American Journal of Surgical Pathology|May 29, 2007
TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasionSven Perner, Juan-Miguel Mosquera, Francesca Demichelis, et al.
Cancer Research|October 7, 2004
JAGGED1 expression is associated with prostate cancer metastasis and recurrenceSandro Santagata, Francesca Demichelis, Alberto Riva, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2010
Skin inflammation arising from cutaneous regulatory T cell deficiency leads to impaired viral immune responsesEva-Jasmin Freyschmidt, Clinton B Mathias, Natalia Diaz, et al.
Cancer Research|April 16, 2009
Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapyMara P Steinkamp, Orla A O'Mahony, Michele Brogley, et al.
Neoplasia (New York, N.Y.)|September 3, 2009
RHAMM (CD168) is overexpressed at the protein level and may constitute an immunogenic antigen in advanced prostate cancer diseaseKilian M Gust, Matthias D Hofer, Sven R Perner, et al.
Urology|December 19, 2009
ERG rearrangement metastasis patterns in locally advanced prostate cancerSven Perner, Maria A Svensson, Ruhella R Hossain, et al.
Cancer Research|February 12, 2004
The role of metastasis-associated protein 1 in prostate cancer progressionMatthias D Hofer, Rainer Kuefer, Sooryanarayana Varambally, et al.
Abdominal Radiology (New York)|September 10, 2018
MR imaging findings of the prostate gland following prostate artery embolization: results from a prospective phase 2 studyRehan Ali, Ahmed Gabr, Samdeep K Mouli, et al.
Neoplasia (New York, N.Y.)|March 15, 2006
Defining aggressive prostate cancer using a 12-gene modelTarek A Bismar, Francesca Demichelis, Alberto Riva, et al.
Pageof 11